Sermorelin at a glance
| Detail | What the sources say |
|---|---|
| What it is | GHRH(1-29), the shortest fragment with the hormone’s full activity |
| US history | Approved as Geref; discontinued by the maker in 2008, approval withdrawn in 2009 |
| FDA determination | Not withdrawn for reasons of safety or effectiveness (Federal Register, 2013) |
| Marketed under the original approval? | No |
From the sources to the app
| What the sources say | What PepLabo does with it |
|---|---|
| No product is marketed under the original approval, so there is no current label to follow [1]. | PepLabo pre-fills nothing: the calculator has no default amount, and the use period after mixing stays empty until you enter it. |
| The approval history spans a diagnostic use and growth hormone deficiency in children [2]. | The library entry lists the status with sources and dates, so you can see what has changed. |
What PepLabo does and does not do
| PepLabo does | PepLabo does not |
|---|---|
| Record each dose with the date, time and amount you enter, and the site for injections | Suggest a dose, a schedule change or a medicine |
| Remind you 15 minutes before, at the dose time, and 30 minutes after a missed dose | Tell you what to do after a missed dose; the leaflet and your prescriber do |
| Put check-ins, weight and doses on one timeline | Interpret symptoms or judge progress |
| Keep your records on your phone, with no account needed to track | Use analytics, advertising or tracking SDKs, or write to Apple Health |
| Create a PDF of your dose log for your clinician (Pro) | Replace your clinician or pharmacist |
